We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 5,368 results
  1. Updates on Anti-seizure Medication Use in Pregnancy

    Purpose of Review

    Care of people with epilepsy and gestational capacity throughout pregnancy involves weighing risks of seizures with the known risks...

    Alexa King, Elizabeth E. Gerard in Current Obstetrics and Gynecology Reports
    Article 03 June 2023
  2. Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy

    Introduction

    Seizures may occur in up to 30% of non-Hodgkin lymphoma patients who received anti-CD19 CAR T-cell therapy, yet the optimal anti-seizure...

    Umberto Pensato, Federica Pondrelli, ... Stefania Bramanti in Neurological Sciences
    Article Open access 21 March 2024
  3. Is anti-seizure medication the culprit of SUDEP?

    Background

    Heart rate variability (HRV) reduction is a potential biomarker for sudden cardiac death. This study aimed to study the effects of...

    Danist Leosuthamas, Chusak Limotai, ... Sasivimol Rattanasiri in Neurological Sciences
    Article 30 May 2023
  4. Association between anti-seizure medication and outcomes in infants

    Objective

    To compare treatment failure between: (1) infants treated with phenobarbital versus levetiracetam for first-line treatment and (2) infants...

    Elizabeth K. Sewell, Shannon E. G. Hamrick, ... Kaashif A. Ahmad in Journal of Perinatology
    Article 20 October 2021
  5. Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region

    Introduction

    The clinical, social, and economic burden of epilepsy is undeniable. Local guidance on epilepsy management is limited and needed to...

    Taoufik Alsaadi, Abubaker Almadani, ... Riaz Ahmed Khan in Neurology and Therapy
    Article Open access 24 May 2023
  6. Psychiatric implications of anti-seizure medications in epileptic population

    Background and objective

    Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is...

    Bushra Khalid, Zaid Waqar, ... Zeeshan Munawar in BMC Neurology
    Article Open access 21 May 2024
  7. Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring

    Objectives

    To determine the association of anti-seizure medication (ASM) treatment with outcomes in acute ischemic stroke (AIS) patients undergoing...

    Paula R. Sanches, Mohammad Tabaeizadeh, ... Sahar F. Zafar in Neurological Sciences
    Article 17 June 2022
  8. Comparing patient reported and medical record data of adverse drug reactions to anti-seizure drugs

    Background

    Anti-seizure drugs (ASDs) can potentially cause serious adverse drug reactions (ADRs). Patient self-reporting can increase the rate of ADR...

    Narumol Jarernsiripornkul, Somsak Tiamkao, ... Sirinya Kampichit in International Journal of Clinical Pharmacy
    Article 16 October 2023
  9. Adherence to anti-seizure medications and associated factors among children with epilepsy at tertiary Hospital in Southwest Ethiopia: a cross-sectional study

    Background

    Childhood epilepsy causes a tremendous burden for the child, the family, society as well as the healthcare system. Adherence to...

    Hawi Mohammed, Kemal Lemnuro, ... Tsegaye Melaku in BMC Neurology
    Article Open access 23 August 2022
  10. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication

    Dravet syndrome is a severe developmental and epileptic encephalopathy characterised by refractory seizures and cognitive dysfunction. The treatment...

    Adam Strzelczyk, Susanne Schubert-Bast in CNS Drugs
    Article Open access 14 February 2022
  11. Network differences based on arterial spin labeling related to anti-seizure medication response in focal epilepsy

    Purpose

    The aim of this study was to determine whether anti-seizure medication (ASM) response is associated with structural connectivity in diffusion...

    Dong Ah Lee, Ho-Joon Lee, ... Kang Min Park in Neuroradiology
    Article 12 July 2021
  12. Long-term antiseizure medication use in patients after meningioma resection: identifying predictors for successful weaning and failures

    Objective

    To define risk factors for meningioma-related seizures and predictors of successful weaning of antiseizure medications following meningioma...

    Erin M. Ellis, Michael R. Drumm, ... Jessica W. Templer in Journal of Neuro-Oncology
    Article 24 October 2023
  13. Distinguishing Benign Rashes From Severe Skin Reactions From Anti-Seizure Medications

    Purpose of review

    This review describes risk factors for severe skin reactions to antiseizure medications (ASMs), the usage of updated tests to...

    Ram Mani, Ahmad Almelegy, ... Cindy Wassef in Current Treatment Options in Neurology
    Article 21 March 2024
  14. Reduction in anti-seizure medications use in pediatric patients with pharmacoresistant epilepsy submitted to surgical treatment

    Purpose

    We aimed to analyze the potential for postoperative (PO) medication suspension and reduction, emphasizing passive withdrawal.

    Methods ...
    Maiave Micaelle Figueiredo de Matos, Larissa Aparecida Batista, ... Ana Paula Andrade Hamad in Child's Nervous System
    Article 29 December 2022
  15. Effects of long-term anti-seizure medication monotherapy on all-cause death in patients with post-stroke epilepsy: a nationwide population-based study in Taiwan

    Objective

    We aim to compare the effect of long-term anti-seizure medication (ASM) monotherapy on the risk of death and new ischemic stroke in patients...

    Chia-Yu Hsu, Chun-Yu Cheng, ... Bruce Ovbiagele in BMC Neurology
    Article Open access 21 June 2021
  16. Impact of seizures and antiseizure medication on survival in patients with glioma

    Purpose

    Seizures are a common presenting symptom among patients with low- and high-grade glioma. However, the impact and inter-relationship between...

    Thinisha Sathis Kumar, Wan Muhammad Afnan, ... Vairavan Narayanan in Journal of Neuro-Oncology
    Article 29 August 2022
  17. Anti-seizure medication is not associated with an increased risk to develop cancer in epilepsy patients

    Objective

    Whether anti-seizure medication (ASM) increases the risk for cancer has been debated for decades. While for some ASM, a carcinoma-promoting...

    Jenny Stritzelberger, Johannes D. Lang, ... Hajo M. Hamer in Journal of Neurology
    Article Open access 23 January 2021
  18. Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China

    Background

    Epilepsy is a severe chronic neurologic disease with a prevalence of 0.7% worldwide; anti-seizure medications (ASMs) are the mainstay of...

    Qiong Zhu, Yi Guo, ... Liang Yu in BMC Neurology
    Article Open access 29 June 2021
Did you find what you were looking for? Share feedback.